- Home
- Publications
- Publication Search
- Publication Details
Title
Cannabidiol Treatment for Refractory Epilepsies in Pediatrics
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-09-29
DOI
10.3389/fphar.2020.586110
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Adjunctive Cannabidiol in Patients with Dravet Syndrome: A Systematic Review and Meta-Analysis of Efficacy and Safety
- (2020) Simona Lattanzi et al. CNS DRUGS
- Cannabidiol efficacy and clobazam status: A systematic review and meta‐analysis
- (2020) Simona Lattanzi et al. EPILEPSIA
- Cannabidiol in treatment of refractory epileptic spasms: An open-label study
- (2020) Aline Herlopian et al. EPILEPSY & BEHAVIOR
- The anticonvulsant effects of cannabidiol in experimental models of epileptic seizures: From behavior and mechanisms to clinical insights
- (2020) Willian Lazarini-Lopes et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Advances in the Treatment of Drug-Resistant Pediatric Epilepsy
- (2020) Ernesto Gonzalez-Giraldo et al. SEMINARS IN NEUROLOGY
- Cannabis for refractory epilepsy in children: A review focusing on CDKL5 Deficiency Disorder
- (2019) Tristan Dale et al. EPILEPSY RESEARCH
- Long-term safety and efficacy of cannabidiol in children and adults with treatment-resistant Lennox-Gastaut syndrome or Dravet syndrome: Expanded access program results
- (2019) Linda C. Laux et al. EPILEPSY RESEARCH
- Cannabidiol Adverse Effects and Toxicity
- (2019) Marilyn A. Huestis et al. Current Neuropharmacology
- Pharmacological and Therapeutic Properties of Cannabidiol for Epilepsy
- (2019) Valentina Franco et al. DRUGS
- Purified Cannabidiol for Treatment of Refractory Epilepsies in Pediatric Patients with Developmental and Epileptic Encephalopathy
- (2019) Nicola Pietrafusa et al. PEDIATRIC DRUGS
- Development of Standard Operating Protocols for the Optimization of Cannabis-Based Formulations for Medical Purposes
- (2019) Francesca Baratta et al. Frontiers in Pharmacology
- Synthetic pharmaceutical grade cannabidiol for treatment of refractory infantile spasms: A multicenter phase-2 study
- (2019) Shaun A. Hussain et al. EPILEPSY & BEHAVIOR
- Efficacy of cannabidiol in subjects with refractory epilepsy relative to concomitant use of clobazam
- (2019) Taylor E. Savage et al. EPILEPSY RESEARCH
- Response to cannabidiol in epilepsy of infancy with migrating focal seizures associated with KCNT1 mutations: An open-label, prospective, interventional study
- (2019) Kelsey Poisson et al. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- The Interplay between the Endocannabinoid System, Epilepsy and Cannabinoids
- (2019) Keith A. Kwan Cheung et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cannabis for Pediatric Epilepsy
- (2019) Richard J. Huntsman et al. JOURNAL OF CLINICAL NEUROPHYSIOLOGY
- Cannabis-based products for pediatric epilepsy: An updated systematic review
- (2019) Jesse Elliott et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Long-term safety and treatment effects of cannabidiol in children and adults with treatment-resistant epilepsies: Expanded access program results
- (2018) Jerzy P. Szaflarski et al. EPILEPSIA
- Efficacy of artisanal preparations of cannabidiol for the treatment of epilepsy: Practical experiences in a tertiary medical center
- (2018) Giulia S. Porcari et al. EPILEPSY & BEHAVIOR
- Open-label use of Highly* purified CBD (Epidiolex®) in patients with CDKL5 deficiency disorder and Aicardi, Dup15q, and Doose syndromes
- (2018) Orrin Devinsky et al. EPILEPSY & BEHAVIOR
- Evidence for cannabis and cannabinoids for epilepsy: a systematic review of controlled and observational evidence
- (2018) Emily Stockings et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial
- (2018) Elizabeth A Thiele et al. LANCET
- Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome
- (2018) Orrin Devinsky et al. NEUROLOGY
- Effect of Cannabidiol on Drop Seizures in the Lennox–Gastaut Syndrome
- (2018) Orrin Devinsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cannabidiol in the Lennox–Gastaut Syndrome
- (2018) NEW ENGLAND JOURNAL OF MEDICINE
- A prospective open-label trial of a CBD/THC cannabis oil in dravet syndrome
- (2018) Bláthnaid McCoy et al. Annals of Clinical and Translational Neurology
- Interaction between warfarin and cannabis
- (2018) Per Damkier et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Efficacy and Safety of Cannabidiol in Epilepsy: A Systematic Review and Meta-Analysis
- (2018) Simona Lattanzi et al. DRUGS
- Long-term cannabidiol treatment in patients with Dravet syndrome: An open-label extension trial
- (2018) Orrin Devinsky et al. EPILEPSIA
- Interactions between cannabidiol and commonly used antiepileptic drugs
- (2017) Tyler E. Gaston et al. EPILEPSIA
- Quality of Life in Childhood Epilepsy in pediatric patients enrolled in a prospective, open-label clinical study with cannabidiol
- (2017) Evan C. Rosenberg et al. EPILEPSIA
- Cannabis and epilepsy: An ancient treatment returns to the fore
- (2017) Ethan B. Russo EPILEPSY & BEHAVIOR
- Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection
- (2017) Evan C. Rosenberg et al. EPILEPSY & BEHAVIOR
- Cannabinoids in treatment-resistant epilepsy: A review
- (2017) Brooke K. O'Connell et al. EPILEPSY & BEHAVIOR
- Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
- (2017) NEW ENGLAND JOURNAL OF MEDICINE
- Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
- (2017) Orrin Devinsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cannabidiol Treatment for Refractory Seizures in Sturge-Weber Syndrome
- (2017) Emma H. Kaplan et al. PEDIATRIC NEUROLOGY
- Plant-Derived and Endogenous Cannabinoids in Epilepsy
- (2016) Alberto Verrotti et al. CLINICAL DRUG INVESTIGATION
- Cannabidiol as a new treatment for drug-resistant epilepsy in tuberous sclerosis complex
- (2016) Evan J. Hess et al. EPILEPSIA
- Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial
- (2016) Orrin Devinsky et al. LANCET NEUROLOGY
- Current understanding and neurobiology of epileptic encephalopathies
- (2016) Stéphane Auvin et al. NEUROBIOLOGY OF DISEASE
- CBD-enriched medical cannabis for intractable pediatric epilepsy
- (2016) Michal Tzadok et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Neural correlates of interactions between cannabidiol and Δ9-tetrahydrocannabinol in mice: implications for medical cannabis
- (2015) S M Todd et al. BRITISH JOURNAL OF PHARMACOLOGY
- Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy
- (2015) Alexandra L. Geffrey et al. EPILEPSIA
- Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox–Gastaut syndrome
- (2015) Shaun A. Hussain et al. EPILEPSY & BEHAVIOR
- Parental reporting of response to oral cannabis extracts for treatment of refractory epilepsy
- (2015) Craig A. Press et al. EPILEPSY & BEHAVIOR
- Cannabidiol as potential treatment in refractory pediatric epilepsy
- (2015) Maria Chiara Paolino et al. Expert Review of Neurotherapeutics
- Molecular Targets of Cannabidiol in Neurological Disorders
- (2015) Clementino Ibeas Bih et al. Neurotherapeutics
- Cannabinoids in the Treatment of Epilepsy
- (2015) Daniel Friedman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pure Cannabidiol in the Treatment of Malignant Migrating Partial Seizures in Infancy: A Case Report
- (2015) Dimah Saade et al. PEDIATRIC NEUROLOGY
- Cannabidiol as potential treatment in refractory pediatric epilepsy
- (2015) Maria Chiara Paolino et al. Expert Review of Neurotherapeutics
- The case for medical marijuana in epilepsy
- (2014) Edward Maa et al. EPILEPSIA
- Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders
- (2014) Orrin Devinsky et al. EPILEPSIA
- Evaluation of phytocannabinoids from high-potency Cannabis sativa using in vitro bioassays to determine structure–activity relationships for cannabinoid receptor 1 and cannabinoid receptor 2
- (2014) Afeef S. Husni et al. MEDICINAL CHEMISTRY RESEARCH
- Cannabidiol Is a Potent Inhibitor of the Catalytic Activity of Cytochrome P450 2C19
- (2013) Rongrong Jiang et al. Drug Metabolism and Pharmacokinetics
- Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy
- (2013) Brenda E. Porter et al. EPILEPSY & BEHAVIOR
- A Phase I, open-label, randomized, crossover study in three parallel groups to evaluate the effect of Rifampicin, Ketoconazole, and Omeprazole on the pharmacokinetics of THC/CBD oromucosal spray in healthy volunteers
- (2013) Colin Stott et al. SpringerPlus
- The Endocannabinoid System and the Brain
- (2012) Raphael Mechoulam et al. Annual Review of Psychology
- Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment
- (2012) Amir Englund et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Host factors affecting antiepileptic drug delivery—Pharmacokinetic variability
- (2011) Cecilie Johannessen Landmark et al. ADVANCED DRUG DELIVERY REVIEWS
- Antiepileptic Drug Interactions - Principles and Clinical Implications
- (2010) Svein I. Johannessen et al. Current Neuropharmacology
- Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies
- (2009) Patrick Kwan et al. EPILEPSIA
- Drug interactions involving the new second- and third-generation antiepileptic drugs
- (2009) Cecilie Johannessen Landmark et al. Expert Review of Neurotherapeutics
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now